Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov record for the upadacitinib giant cell arteritis study is displayed, including its design, eligibility criteria, outcomes, locations, and study documents, in place of an access error.SummaryDifference100%

- Check19 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a terminology transition.SummaryDifference1%

- Check33 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 error instead of the study record. Its footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error screen instead of the usual study-record content, with a Home button indicating restricted access rather than an update to the study data.SummaryDifference20%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.